Nucleosides and their
analogues constitute an important
family
of molecules with potential antiviral and antiproliferative activity.
The enantiomers of natural nucleosides, l-nucleoside derivatives,
which have comparable biological activity but more favorable toxicological
properties and greater metabolic stability than d-nucleosides,
have emerged as a new class of therapeutic agents. Furthermore, l-nucleosides can be used as a building block to prepare l-oligonucleotides, which have identical physical properties
in terms of solubility, hybridization kinetics, and duplex thermal
stability as d-oligonucleotides but completely orthogonal
in nature. Consequently, they are resistant to nuclease degradation,
nontoxic, and immunologically passive, which are desirable properties
for biomedical applications. Herein, we describe the synthesis of
several 2′-O-methyl/2′-O-MOE-l-nucleoside pyrimidine derivatives and their incorporation
into G-rich oligonucleotides. Finally, we evaluated the stability
and resistance against nucleases of these new G-quadruplexes, demonstrating
the potential of the l-nucleosides described in this work
in providing enhanced nuclease resistance with a minimal impact in
the nucleic acid structural properties.